The pharmaceutical industry is undergoing a profound transformation driven by advancements in Information Technology (IT), with Enterprise Resource Planning (ERP) systems playing a pivotal role in reshaping operations. These systems offer integrated solutions that streamline key business processes, such as production, inventory management, supply chain optimization, regulatory compliance, and data integration, contributing significantly to operational efficiency and organizational agility. This paper explores the evolution and impact of ERP systems within the pharmaceutical sector, highlighting their contributions to overcoming the industry’s inherent challenges, including complex regulatory requirements, the need for accurate and real-time data, and the demand for supply chain resilience. The integration of cloud-based ERP solutions, the incorporation of emerging technologies like Artificial Intelligence (AI), Machine Learning (ML), and the Internet of Things (IoT), and enhanced data analytics capabilities have revolutionized pharmaceutical IT. These advancements not only reduce operational costs, improve forecasting accuracy, and enhance collaboration but also ensure compliance with stringent global regulations, such as Good Manufacturing Practices (GMP) and FDA guidelines. Moreover, ERP systems have been instrumental in managing the pharmaceutical supply chain, ensuring product traceability, and improving inventory control and order fulfillment processes. This manuscript examines how ERP systems enable pharmaceutical companies to maintain high standards of product quality, improve decision-making, and ensure the safety and efficacy of drugs through robust tracking and auditing mechanisms. A case study of a pharmaceutical company that implemented an ERP system demonstrates the tangible benefits, including increased operational efficiency, improved compliance rates, and enhanced customer satisfaction. However, despite the clear advantages, challenges such as customization complexities, data integration issues, and resistance to change remain. As the pharmaceutical industry continues to evolve, ERP systems will remain a cornerstone of digital transformation, facilitating smarter decision-making, better resource management, and enhanced collaboration across global operations. This paper also identifies future trends, including the potential of AI and blockchain technologies in further strengthening ERP systems and transforming the pharmaceutical landscape.

The SAP HANA Application to handle operational workloads that are consistent with transactions while also supporting intricate business analytics operations. Technically speaking, the SAP HANA database is made up of several data processing engines that work together with a distributed query processing environment to provide the entire range of data processing capabilities. This includes graph and text processing for managing semi-structured and unstructured data within the same system, as well as classical relational data that supports both row- and column-oriented physical representations in a hybrid engine. The next-generation SAP Business Suite program designed specifically for the SAP HANA Platform is called SAP S/4HANA. The key features of SAP S/4HANA are an intuitive, contemporary user interface (SAP Fiori); planning and simulation options in many conventional transactions; simplification of business processes; significantly improved transaction efficiency; faster analytics.

The review article presents how emerging technologies improves the business enterprise applications for process management. The paper considers certain technologies of enterprise applications and justifies the updated methodological and analytical tools for assessing, selecting, and regulating business processes in a single enterprise resource planning (ERP) system. Information technology must be used to identify products, track their movement into and out of the warehouse using code scanning technology, and streamline the product management procedure. To increase the dependability of management techniques, guarantee that the business operates flawlessly, and maintain a regular management mode, the process management form should be implemented in the enterprise management process. The implementation of digital information technology is essential for achieving effective corporate management. In addition to providing ideal operational circumstances for businesses, it is essential to analyse information technology and manage businesses economically. The foundation for implementing the enterprise applications method strategy is the creation of a process management system and an in-depth, methodical review of the enterprise as a collection of processes. Process-oriented enterprise applications should be the foundation of contemporary novel technologies for modelling business processes. It shares a tight relationship with workflow management systems (WFM), enterprise resource planning (ERP), and total quality management (TQM).

The management of supply chains is increasingly complex. This study provides a comparative analysis of the cost-benefit analysis for managing various risks. It identifies the financial implications of leveraging artificial intelligence in supply chains to better address risk. Empirical results show a business case for managing some sources of risk more proactively facilitated through predictive modeling techniques offered by AI. Across investigation streams, the use of AI results in an average total cost saving ranging from 41,254 to 4,099,617. Findings from our research can be used to inform managers and theorists about the implications of integrating AI technologies to manage risks in the supply chain. Our work also highlights areas for future research. Given the growing interest in studying sub-second forecasting, our research could be a point of departure for future investigations aimed at considering the impact of forecasting horizons such as an intra-day basis. We formulate a conceptual framework that considers how and to what extent performance evaluation metrics vary according to differences in the fidelity of predictive models and factor importance for identifying risks. We also utilize a mixed-method approach to demonstrate the applicability of our ideas in practice. Our results illustrate the financial implications of integrating AI predictive tools with business processes. Results suggest that real-world companies can circumvent inefficiencies associated with trying to manage many classes of risk via the use of AI-enhanced predictive analytics. As managers need to justify investment to top management, our work supports decision-making by providing a means of conducting a trade-off analysis at the tactical level.